focus
Previous article:
Alkermes shareholders re
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
Next article: Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
focus
leisure time
-
Harvard's David Sinclair gets blowback over aging
2025-09-28 23:01 -
Humana cuts profit projections as Medicare Advantage costs soar
2025-09-28 22:59 -
Prior authorization will have to move faster under new Biden rule
2025-09-28 22:19 -
Test for long Covid? Researchers find new clue in blood samples
2025-09-28 22:10 -
EU regulator recommends expanding Mounjaro approval to obesity
2025-09-28 21:58 -
Humana cuts profit projections as Medicare Advantage costs soar
2025-09-28 21:45